Plant Molecular Biology and Biotechnology Division, CSIR-Indian Institute of Integrative Medicine (IIIM), Sanatnagar, Srinagar, Jammu & Kashmir-190005, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh-201002, India.
FEMS Microbiol Ecol. 2024 Mar 12;100(4). doi: 10.1093/femsec/fiae026.
The increasing global concern of antimicrobial resistance and shortage of new antimicrobials necessitates exploring untapped terrestrial environments for new bioactive microbiome diversity. The low-temperature and oligotrophic North Western Himalaya (NWH) region has a vast diversity of Streptomyces with potential antimicrobial properties that remain largely unexplored. This study evaluates the diversity of culturable Streptomyces from high-altitude NWH and their potential as a source of new antimicrobials through genus-specific isolation and identification. The results demonstrate a distinct phylogenetic clustering of Streptomyces from different sampling regions of NWH, site-specific variation in culturable β-diversity and species commonness with varying intersite bioactivity among different sites. Further, the study optimized the media selection for large-scale culture cultivation in antibiotic production processes and demonstrated the antimicrobial efficacy of Streptomyces against a range of pathogens through in vitro bioassays using minimum inhibitory concentration determination and antibiofilm activity. Untargeted label-free proteomic profiling also revealed variable expression of stress-response proteins and antibiotic regulators as a competitive survival strategy for selective antagonistic Streptomyces. The findings highlight the potential of NWH in augmenting antimicrobial discovery and combating antimicrobial resistance through the isolation and study of novel bioactive Streptomyces.
全球对抗微生物耐药性的关注度不断增加,新抗菌药物的短缺也亟待解决,因此需要在未被开发的陆地环境中探索新的具有生物活性的微生物多样性。低温、贫营养的喜马拉雅山西北部(NWH)地区拥有丰富的具有潜在抗菌特性的链霉菌多样性,但这些多样性在很大程度上尚未得到探索。本研究通过属特异性分离和鉴定,评估了来自高海拔 NWH 的可培养链霉菌的多样性及其作为新型抗菌药物来源的潜力。研究结果表明,来自 NWH 不同采样区域的链霉菌具有明显的系统发育聚类,可培养的β多样性在特定地点存在差异,不同地点之间的物种常见性和不同地点之间的生物活性存在差异。此外,本研究还优化了抗生素生产过程中的大规模培养培养基选择,并通过使用最小抑菌浓度测定和抗生物膜活性的体外生物测定,展示了链霉菌对一系列病原体的抗菌功效。非靶向无标签蛋白质组学分析还揭示了应激反应蛋白和抗生素调节剂的可变表达,这是选择性拮抗链霉菌的一种竞争生存策略。这些发现强调了 NWH 在通过分离和研究新型生物活性链霉菌来增强抗菌药物发现和对抗抗菌药物耐药性方面的潜力。